CoChat

What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

BACKGROUND: In the United States, $50,000 per Quality-Adjusted Life-Year (QALY) is a decision rule that is often used to guide interpretation of cost-effectiveness analyses. However, many investigators have questioned the scientific basis of this rule, and it has not been updated. METHODS: We used 2 separate approaches to investigate whether the $50,000 per QALY rule is consistent with current resource allocation decisions. To infer a lower bound for the decision rule, we estimated the incremental cost-effectiveness of recent (2003) versus pre-"modern era" (1950) medical care in the United States. To infer an upper bound for the decision rule, we estimated the incremental cost-effectiveness of unsubsidized health insurance versus self-pay for nonelderly adults (ages 21-64) without health insurance. We discounted both costs and benefits, following recommendations of the Panel on Cost-Effectiveness in Health and Medicine. RESULTS: Our base case analyses suggest that plausible lower and upper bounds for a cost-effectiveness decision rule are $183,000 per life-year and $264,000 per life-year, respectively. Our sensitivity analyses widen the plausible range (between $95,000 per life-year saved and $264,000 per life-year saved when we considered only health care's impact on quantity of life, and between $109,000 per QALY saved and $297,000 per QALY saved when we considered health care's impact on quality as well as quantity of life) but it remained substantially higher than $50,000 per QALY. CONCLUSIONS: It is very unlikely that $50,000 per QALY is consistent with societal preferences in the United States.

Overview

Integrity signals

Registry

Crossref · 10.1097/mlr.0b013e31815c31a7

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Research works printed but not linked: 4

  1. Taylor, 2003, Why not spend more on health care?, Health Interactive Health Care News, 3, 12
  2. 2002, Life Expectancy by Age, Race, and Sex: Death Registration States, 1900–1902 to 1919–1921, and United States, 1929–1931 to 2000. Table 11. US Census Bureau., Natl Vital Stat Rep, 51, 29
  3. 2002, Life Table for the Total Population: United States, 2002. Table 1. US Census Bureau., Natl Vital Stat Rep, 53, 7
  4. Braithwaite, 2005, $50,000 per QALY: inertia, indifference, or irrationality?, Med Decis Making, 25, E1

Cited by

See all 584

Metadata

Authors
Braithwaite, R. S., Meltzer, D. O., King, J. T., Leslie, D., & Roberts, M. S.
Affiliations
  • Yale University (US)
  • University of Chicago (US)
  • United States Department of Veterans Affairs (US)
  • University of Pittsburgh (US)
Corresponding author
Braithwaite, R Scott
Venue
Medical Care
Published
2008-04
Volume
46
Issue
4
Pages
349-356
ISSN
0025-7079 (ISSN-L)
OpenAlex
W2134047636
Cited by
579
References
33
Citations by year
2026: 1 · 2025: 18 · 2024: 12 · 2023: 15 · 2022: 22 · 2021: 23 · 2020: 26 · 2019: 36 · 2018: 31 · 2017: 50 · 2016: 43 · 2015: 48 · 2014: 49 · 2013: 47 · 2012: 45
FWCI
85.89
Type
journal article
Language
en
Open access
closed
Locations
  • Medical Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Keywords
quality-adjusted life years, cost-effectiveness threshold, resource allocation, incremental cost-effectiveness, uninsured adults, health insurance, health care spending, societal preferences, discounting
MeSH terms
Adult, Cost-Benefit Analysis, Decision Support Techniques, Female, Health Policy, Humans, Insurance, Health, Life Expectancy, Male, Middle Aged, Reference Values, Time Factors, United States, Health Care Rationing, Age Distribution, Quality-Adjusted Life Years

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? https://app.cochat.ai/papers/10.1097/mlr.0b013e31815c31a7
The paper
Braithwaite, R. S., Meltzer, D. O., King, J. T., Leslie, D., & Roberts, M. S. (2008). What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? Medical Care. https://doi.org/10.1097/mlr.0b013e31815c31a7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.